6-53564474-A-G
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000505197.1(GCLC):c.-313-54T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.146 in 152,206 control chromosomes in the GnomAD database, including 1,697 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
ENST00000505197.1 intron
Scores
Clinical Significance
Conservation
Publications
- gamma-glutamylcysteine synthetase deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000505197.1. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.146 AC: 22195AN: 152066Hom.: 1694 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.318 AC: 7AN: 22Hom.: 2 AF XY: 0.286 AC XY: 4AN XY: 14 show subpopulations
GnomAD4 genome AF: 0.146 AC: 22207AN: 152184Hom.: 1695 Cov.: 32 AF XY: 0.149 AC XY: 11081AN XY: 74402 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at